drugset / Trial / NCT03375606
Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults
RandomizedSequentialQuadruple-blindOther
Summary
To assess the safety and tolerability of ascending doses of CSL730 after a single intravenous (IV) infusion in healthy Caucasian and Japanese subjects
Timeline
- Start
- 2018-01-10
- Primary completion
- 2020-06-22
- Completion
- 2020-06-22
Outcome
Outcome not reported
Stopped: “The Sponsor decided to terminate this study in favor of development of subcutaneous administration.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CSL730 | Protein / enzyme biologic | — | Intravenous |
Indications
No indication recorded.